New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen-3-yl) propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

被引:50
|
作者
Martínez, J
Pérez, S
Oficialdegui, AM
Heras, B
Orús, L
Villanueva, H
Palop, JA
Roca, J
Mourelle, M
Bosch, A
Del Castillo, JC
Lasheras, B
Tordera, R
del Río, J
Monge, A
机构
[1] Univ Navarra, Dept Med Chem, E-31080 Pamplona, Spain
[2] Univ Navarra, CIFA, E-31080 Pamplona, Spain
[3] Univ Navarra, Dept Pharmacol, E-31080 Pamplona, Spain
[4] Vita Invest SA, Barcelona 08970, Spain
关键词
arylpiperazines; antidepressant; 5-HT1A antagonist; serotonin reuptake inhibitor;
D O I
10.1016/S0223-5234(00)01198-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives were synthesized in an attempt to find a new class of antidepressant drugs with dual activity at 5-HT1A serotonin receptors and serotonin transporter. Title compounds were evaluated for in vitro activity on 5-HT1A receptor and 5-HT transporter. They show high nanomolar affinity for both activities, and in particular, compounds 1-(5-chlorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (7) and 1-(5-fluorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl) piperain-1-yl]propan-1-ol (8) show values (nM) of K-i = 30 and 2.3 for 5-HT1A receptors and K-i = 30 and 12 for serotonin transporters, respectively. In GTP gammaS binding assays, compound 8 revealed antagonist properties to 5-HT1A receptors. Such a pharmacological profile could lead to potent antidepressant agents with new dual mechanism of action. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 25 条
  • [1] Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action:: serotonin reuptake inhibition and 5-HT1A receptor antagonism
    Oficialdegui, AM
    Martinez, J
    Pérez, S
    Heras, B
    Irurzun, M
    Palop, JA
    Tordera, R
    Lasheras, B
    del Río, J
    Monge, A
    FARMACO, 2000, 55 (05): : 345 - 353
  • [2] New 3-(4-arylpiperazin-1-yl)-1-(benzo[b]thiophen-3-yl)-2-methylpropanol derivatives:: Synthesis and evaluation for dual 5-HT1A/SSRI activities
    Li, Ai Jun
    Zhang, Xiao Hua
    Zhou, Xue Qin
    Liu, Dong Zhi
    CHINESE CHEMICAL LETTERS, 2008, 19 (04) : 412 - 414
  • [4] Synthesis, Docking Studies and Biological Evaluation of Benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one Derivatives on 5-HT1A Serotonin Receptors
    Pessoa-Mahana, Hernan
    Recabarren-Gajardo, Gonzalo
    Fiedler Temer, Jenny
    Zapata-Torres, Gerald
    David Pessoa-Mahana, C.
    Saitz Barria, Claudio
    Araya-Maturana, Ramiro
    MOLECULES, 2012, 17 (02): : 1388 - 1407
  • [5] Studies towards the next generation of antidepressants.: Part 4:: Derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor
    Evrard, DA
    Zhou, P
    Yi, SY
    Zhou, DH
    Smith, DL
    Sullivan, KM
    Hornby, GA
    Schechter, LE
    Andree, TH
    Mewshaw, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 911 - 914
  • [6] Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl) pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT
    Wrobel, Martyna Z.
    Chodkowski, Andrzej
    Dawidowski, Maciej
    Siwek, Agata
    Stachowicz, Katarzyna
    Szewczyk, Bernadeta
    Nowak, Gabriel
    Satala, Grzegorz
    Bojarski, Andrzej J.
    Turlo, Jadwiga
    BIOORGANIC CHEMISTRY, 2023, 141
  • [7] Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT1A and D2 receptor affinity and serotonin transporter inhibition
    Wrobel, Martyna Z.
    Chodkowski, Andrzej
    Marciniak, Monika
    Dawidowski, Maciej
    Maksymiuk, Anna
    Siwek, Agata
    Nowak, Gabriel
    Turlo, Jadwiga
    BIOORGANIC CHEMISTRY, 2020, 97
  • [8] Discovery of a Novel 5-HT3 Antagonist/5-HT1A Agonist 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an Orally Bioavailable Agent for Irritable Bowel Syndrome
    Asagarasu, Akira
    Matsui, Teruaki
    Hayashi, Hiroyuki
    Tamaoki, Satoru
    Yamauchi, Yukinao
    Minato, Kouichi
    Sato, Michitaka
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (21) : 7549 - 7563
  • [9] Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanones: new derivatives of 1,3,5-trisubstituted pyrazolines
    Kumar, Satyender
    Meenakshi
    Kumar, Sunil
    Kumar, Parvin
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (01) : 433 - 439
  • [10] Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent
    Kumari, Shikha
    Mishra, Chandra Bhushan
    Tiwari, Manisha
    PHARMACOLOGICAL REPORTS, 2016, 68 (02) : 250 - 258